Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Account Payables: 2023-2025

Historic Change in Account Payables for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $1.4 million.

  • Upstream Bio's Change in Account Payables rose 905.17% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$926,000, marking a year-over-year decrease of 119.94%. This contributed to the annual value of $2.0 million for FY2024, which is 57.82% up from last year.
  • As of Q3 2025, Upstream Bio's Change in Account Payables stood at $1.4 million, which was up 164.65% from -$2.2 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Change in Account Payables peaked at $3.7 million during Q2 2024, and registered a low of -$2.2 million during Q2 2025.
  • Over the past 3 years, Upstream Bio's median Change in Account Payables value was $268,500 (recorded in 2024), while the average stood at $464,875.
  • Within the past 5 years, the most significant YoY rise in Upstream Bio's Change in Account Payables was 905.17% (2025), while the steepest drop was 158.93% (2025).
  • Quarterly analysis of 3 years shows Upstream Bio's Change in Account Payables stood at $1.8 million in 2023, then slumped by 149.57% to -$871,000 in 2024, then skyrocketed by 905.17% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, -$2.2 million for Q2 2025, and $711,000 during Q1 2025.